Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 154Neoplasms 113Carcinoma, Non-Small-Cell Lung 84Prostatic Neoplasms 81Lung Neoplasms 74Colorectal Neoplasms 73Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 50Pancreatic Neoplasms 43Neoplasm Metastasis 42Multiple Myeloma 36Recurrence 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Stomach Neoplasms 28Brain Neoplasms 27Triple Negative Breast Neoplasms 26Squamous Cell Carcinoma of Head and Neck 26Ovarian Neoplasms 26Melanoma 26Glioblastoma 25Head and Neck Neoplasms 24Uterine Cervical Neoplasms 21Small Cell Lung Carcinoma 21Rectal Neoplasms 21Carcinoma, Renal Cell 20Lymphoma 19Lymphoma, Follicular 18Glioma 18Endometrial Neoplasms 18Sarcoma 17

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × High-Risk Localized Prostate Cancer × 90 days × Clear all
NCT07550517 2026-04-24

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

High-Risk Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡